Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18263
Title: Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antibiotics, Antineoplastic/adverse effects/*therapeutic use,Carcinoma, Non-Small-Cell Lung/*drug therapy,Female,Hematopoiesis/drug effects,Humans,Lactones/adverse effects/therapeutic use,Lung Neoplasms/*drug therapy,Macrolides,Male,Middle Aged
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/18263
ISSN: 0007-0920
Link: http://www.ncbi.nlm.nih.gov/pubmed/8562351
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Pavlidis-1996-single agent activity.pdf612.33 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons